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Abstract 
GABA is the principal inhibitory neurotransmitter in 
the mammalian CNS. It acts via two classes of receptors, 
the GABAA, a ligand gated ion channel (ionotropic 
receptor) and the metabotropic G-protein coupled GABAB 
receptor. While synaptic GABAA receptors underlie 
classical ‘phasic’ GABAA receptor-mediated inhibition, 
extrasynaptic GABAA receptors (eGABAAR) mediate a 
new form of inhibition, termed ‘tonic’ GABAA inhibition. 
The subunit composition of eGABAARs differs from those 
present at the synapse, resulting in pharmacologically and 
functionally distinct properties. In this mini-review the 
findings presented at the 2nd Neuroscience Day meeting 
held last July in Malta will be summarised. Particular 
emphasis will be given to the important pathophysiological 
role of eGABAAR within thalamocortical circuits as a 
major player in nonconvulsive absence epilepsy. The new 
findings presented at the conference suggest that enhanced 
tonic inhibition is a common cause of seizures in several 
animal models of absence epilepsy and may provide new 
targets for therapeutic intervention. 
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Introduction 
The action of γ-aminobutyric acid (GABA), the 
principal inhibitory neurotransmitter in the brain, is 
mediated by ligand-gated ion channels and 
metabotropic receptors known as GABAA and GABAB 
receptors, respectively.1 GABAA receptors are 
pentameric assemblies of subunits that form a central 
ion channel which opens upon GABA binding, 
increasing membrane permeability to both bicarbonate 
and chloride ions.1 This typically occurs during a 
transient rise in GABA concentration within the 
synaptic cleft and the activation of postsynaptic 
receptors, caused by the release of GABA from 
presynaptic terminals. This resulting brief change in 
membrane conductance is the underlying factor in 
“phasic” GABAAergic inhibition and generation of a 
“classical” inhibitory postsynaptic potential (IPSP). In 
this case, both the increase in conductance (that causes 
shunting of excitatory inputs) and the 
hyperpolarisation (that reduces depolarisations) 
contribute to the 'inhibitory' effect of GABA, thereby 
reducing the probability that an action potential will be 
initiated. A hyperpolarizing GABA response might not 
be inhibitory if it triggers hyperpolarization-activated 
excitatory conductances to produce rebound spikes.2 
Moreover, the response to GABA itself can be 
depolarizing. This is true for most immature neurons 
that lack K+-Cl- cotransporter (KCC2) and instead 
accumulate Cl- via the Na+-K+-coupled co-transporter 
(NKCC1),3 and also occurs in some mature neurons.4 
 
There is a great potential for heterogeneity in 
GABA receptor assembly since nineteen GABAA 
receptor subunits have been cloned from the 
mammalian CNS (α(1–6), β(1–3), γ(1–3), δ, ε, θ, π, 
ρ(1–3)). Significantly, the postsynaptic densities of 
GABAA-ergic synapses are highly enriched with 
receptors, including α(1–3), α6, β(2-3), and γ2 
subunits5 suggesting that these subunits form the 
GABAA receptors responsible for classical “phasic” 
inhibition. A different subtype of GABAA receptor has 
also been described, previously known as the GABAC 
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receptor, recently renamed GABAA-ρ since exclusively 
composed of 3 ρ subunits. Stimulation of GABAA-ρ 
receptors produces a slow to initiate, but sustained in 
duration, chloride current and has 10 times more affinity 
for GABA6.  
 
In addition to phasic inhibition, it has recently been 
shown that GABAA receptor activation can occur in a 
much more spatially and temporally diffuse manner.1 This 
been identified in different brain areas such as the 
cerebellum,7 hippocampus8 and thalamus,9-11 where the 
very low concentrations of GABA (in the range of nM) 
found in the extracellular space, can activate persistently a 
population of nonsynaptic GABAA receptors, resulting in a 
“tonic” increase in membrane conductance. These peri or 
extrasynaptic GABAA receptors (eGABAARs) are 
excellent sensors for extracellular GABA and have indeed 
a significantly higher affinity for GABA compared to 
those receptors located at the synapses and in addition a 
slower rate of desensitization.1,12-14 However, as recently 
shown, significant desensitization of eGABAARs can also 
occur at ambient GABA concentrations in the visual 
thalamus.15 The differences in the properties of synaptic 
GABAARs and eGABAARs is a result of receptor subunit 
composition, particularly the inclusion of the δ subunit in 
the dentate gyrus granule cells, cerebellar granule cells, 
thalamocortical (TC) and some cortical neurons8-11,16,17 and 
α5 subunits in CA1 and CA3 hippocampal pyramidal 
cells.18-20 The δ subunit containing eGABAARs coassemble 
with 2 α (α4 or α6) and 2 β subunits. The α5 subunit 
containing eGABAAR usually coassemble with α, β and γ2 
subunit that is typically located at the synaptic space. α1 
and α2 subunits as well as β3 subunits are also found at 
extrasynaptic locations on the soma of hippocampus CA1 
pyramidal neurons suggesting that these subunits may also 
contribute to eGABAAR signalling and perhaps confer 
specific pharmacological properties.21 
 
In vitro studies have demonstrated that thalamic TC 
neurons of the dorsal lateral geniculate9 and the 
ventrobasal (VB) nucleus9-11 have robust GABAA-ergic 
tonic currents in rodents, which are largely mediated by 
α4β2δ subunit-containing receptors. Electrophysiological 
evidence corroborated by high expression of the δ-subunit 
containing GABAAR in all thalamic nuclei.17,22-24 
Mounting evidence in recent years has made it clear that 
eGABAARs-mediated tonic inhibition plays a paramount 
role in modulating neuronal excitability. It is likely that 
this uninterrupted GABA conductance controls the overall 
gain of the neuronal input-output.25 
 
It is noteworthy that eGABAARs tonic inhibition may 
not remain constant in its magnitude over time but 
fluctuates in relation to extracellular GABA 
concentration.26 Moreover, this tonic outward background 
current can be modulated by noradrenalin, dopamine 
and serotonin (unpublished observations), 
neurosteroids and alcohol. As far as the thalamus is 
concerned, tonic currents resulting from activation of 
eGABAARs are responsible for 80-90% of total 
GABAA receptor-mediated inhibition.9,11 Further, it 
has been suggested that tonic conductance in TC 
neurons may be larger than in other regions expressing 
eGABAARs including the cerebellum and dentate 
gyrus.11 eGABAARs might play a role in switching the 
behavioural state-dependent TC neuron firing modes9 
and modulating the temporal precision of rebound 
low-threshold Ca2+ spikes (LTS). 23 Given the integral 
role of TC neurons in generating low-frequency (<4 
Hz) oscillations in corticothalamic circuits,9,11 it seems 
likely that eGABAARs are significant in the 
modulation of slow wave sleep (SWS) activity. 
Furthermore, the potential importance of these 
receptors in typical absence epilepsy has recently been 
described.27 
 
Typical absence epilepsy, characterised by the 
regular occurrence of nonconvulsive seizures that 
result in periods of sudden and brief loss of 
consciousness, appears in the electroencephalogram 
(EEG) as generalized synchronous, and bilateral 
“spike (or polyspike) and slow wave discharges 
(SWDs)”. The SWDs occur at frequencies between 
2.5-4 Hz.28,29 Childhood epilepsy accounts for 2-10% 
of childhood epilepsies, with annual incidence of 2-8 
per 100,000. Age of onset is typically 4-8 years (peak 
at 6 years) and seizure frequency may be as high as 
several hundred events per day.29 These absence 
seizures are neither triggered by visual or other 
sensory stimuli nor usually associated with 
neurometabolic or neurophysiological deficits, a factor 
which is thought relevant to ~70% spontaneous 
remission rates in adolescence.29,30 Absence seizures 
are generated in reciprocal cortico-thalamo-cortical 
networks.29 The thalamus is required for the full 
expression of seizures in terms of both electrographic 
and behavioural aspects,31 although it is not directly 
involved in seizure initiation.  
 
Recent imaging investigations have challenged the 
notion that typical absence seizure is ‘generalized’. 
According to the “theory of the initiation site”, seizure 
genesis seems to occur as a result of aberrant electrical 
activity in discrete cortical regions, i.e. the perioral 
region of the somatosensory cortex and the frontal and 
parietal cortices in animal models and humans, 
respectively.32-37  
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Figure 1: Increased tonic GABAA inhibition in genetic and pharmacological models of absence seizures.  
A. Representative current traces from thalamocortical neurons of P14 (top) and P17 (bottom) NEC 
rats and GAERS, indicating the presence of tonic GABAA currents after the focal application of 
100 μM gabazine (GBZ, white bars). Dotted lines indicate the continuation of the initial baseline 
current for each neuron.  
B. Comparison of the tonic current amplitude in NEC rats and GAERS at the indicated ages.  
C. Comparison of tonic current amplitude in wild type (WT) and GAT–1–knockout (KO) mice. 
Numbers of recorded neurons are as indicated.  
D. Simultaneous, bilateral EEG traces from a normal Wistar rat after intrathalamic administration of 
artificial cerebrospinal fluid (aCSF, top traces) and then 200 μM NO711 (bottom traces). Second 
from bottom is a spectrogram for the lowest trace L. At the bottom is an enlargement of the single 
SWD, indicated BY (•). Calibration bars for the enlarged SWD; vertical 200 μV, horizontal 1 s.  
E. Comparison of the effect of ethosuximide (ETX) (200 mg/kg/ip) on the total time (1 h) spent in 
seizure. Number of recorded mice is as indicated. Modified from27. 
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Tonic eGABAAR-Mediated Inhibition in Absence 
Epilepsy: Experimental evidence 
We have recently showed that the tonic GABAA 
current in TC neurons of the VB thalamus results were 
enhanced in several different genetic (Figure 1) (i.e. the 
polygenic GAERS model and the monogenic models 
stargazer and lethargic mice) as well as pharmacological 
(i.e. gamma-hydroxybutyrate, GHB, and 4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridin-3-o, THIP) models of 
absence seizures.27 In addition, eGABAA conductance is 
increased in TC neurons of GABA transporter-1 (GAT-1) 
knock-out (KO) mice, which we showed to have SWDs 
and behavioural arrest typical of absence epilepsy.27 In 
GAERS, the tonic GABAA inhibition in VB TC neurons 
develops gradually after birth, reaching the maximal 
values at the postnatal day 29/30 doubling the tonic 
inhibition recorded in NEC, the nonepileptic control strain. 
The pathological enhancement of tonic GABA inhibition 
during development in GAERS may be proepileptogenic 
rather than simply due to the stressful effects of the 
seizures, since it is already present at postnatal day 17 
before the seizure onset that happens around postnatal day 
30 (Figure 1A,B). In addition, the monogenic lethargic and 
stargazer mice showed a similar significant enhancement 
of tonic current in TC neurons after seizure onset.27  
 
The aberrant increase of tonic GABAA currents in VB 
TC neurons seems to be independent to changes in 
vesicular GABA release, expression of δ-subunit 
containing eGABAARs or synaptic GABAAR. Strikingly, a 
dysfunction of GAT-1 expressed on astrocytes in the 
thalamus has been revealed in all the genetic animal 
models of absence epilepsy tested. Therefore, a deficiency 
in astrocytic GABA uptake through the GAT-1 seems to 
be a common pathological mechanism shared by different 
animal models. 
 
These results raise the possible scenario in which 
absence seizures are due to an impairment of glial GAT-1 
in the VB of the thalamus that leads to an increase in 
extrasynaptic GABA concentration and, in turn, an 
aberrant enhancement of tonic eGABAA current. Enhanced 
tonic GABAA inhibition in TC neurons would generate 
typical absence seizures. 
 
This hypothesis is confirmed by our recent 
experimental findings27. GAT-1 KO mice display 
enhanced tonic GABAA currents in TC neurons and 
express ethosuximide-sensitive typical absence seizures. 
Furthermore, infusion by reverse microdialysis of the 
GAT-1 blocker NO-711 in the VB of nonepileptic Wistar 
rats induced ethosuximide-sensitive typical absence 
seizures (Figure 1D).27 In addition, systemic 
administration of the proepiloptegenic GHB failed to 
induce absence seizures in δ−/− mice, which exhibit a 
nearly ablated tonic GABAA inhibition in TC neurons. 
Intrathalamic injection of a δ subunit-specific antisense 
oligodeoxynucleotide strongly decreased both tonic 
GABAA current and spontaneous seizures in GAERS.27 
Finally, local administration of THIP, a selective agonist 
for the δ-subunit containing eGABAAR, in the VB of 
normal Wistar rats induced ethosuximide-sensitive 
absence seizures.27  
 
In spite of our recent findings, there are quite a 
number of important unresolved issues surrounding 
the tonic GABAA conductance in absence epilepsy that 
have yet to be addressed experimentally. For example, 
we do not know exactly how the increase of the 
GABAA tonic conductance in VB cell might produce 
the genesis of SWDs. We can only speculate since 
final evidence is missing. What we know is that SWDs 
of typical absence epilepsy appear to be initiated in 
deep layers of the cortex, where rhythmic paroxysmal 
depolarisations occur in phase with the EEG spike.31,39 
Strong rhythmic input to thalamic nuclei is provided 
by the action potentials associated with these 
synchronous depolarisations. This strong converging 
corticothalamic input produces bursts of excitatory 
postsynaptic potentials that trigger T-type Ca2+-
channel-mediated LTS and bursts of action potentials 
in NRT neurons. Conversely, both monosynaptic 
excitation directly from corticothalamic inputs and 
disynaptic inhibition via the NRT are received by TC 
neurons. During ictal activity, TC neurons are 
generally silent31,37,39 as result a result of a much 
stronger corticothalamic excitatory inputs into NRT 
neurons compared to TC neurons.40 It is therefore 
probable that during SWDs the strong NRT 
GABAergic input into TC neurons activating 
eGABAARs produces a corresponding increase in 
tonic current. Hypothetically, this could in turn 
contribute to the observed inhibition of TC neuron 
output during ictal activity. 
 
Concluding remarks 
The evidence presented at the Second 
Neuroscience Day at Malta University suggests that in 
both pharmacological and genetic models of typical 
absence seizures the augmented tonic GABAA 
inhibition in TC neurons may lead to the expression of 
SWDs. Another important discovery is the prominent 
role played by glial cells in absence epilepsy. Ambient 
GABA levels around TC neurons is abnormally 
increased due to reduced GABA uptake by astrocytic 
GAT-1, enhancing eGABAAR function. Strikingly, 
this type of nonconvulsive epilepsy seems to have, 
therefore, a glial aetiology rather than a neuronal one. 
We still do not know the exact cause of GAT-1 
hypofunction. Nevertheless, we could not reveal any 
decreased thalamic or cortical expression of GAT-1 
mRNA or protein levels or the presence of any genetic 
variants in GAT-1 cDNA from different animal 
models. We can hypothesize that the GAT-1 
impairment could be related to its cytoplasmatic 
mobilization or phosphorylation processes.  
 
In conclusion, development of antagonist, or even 
better, inverse agonists selective for eGABAARs may 
have potential therapeutic value in absence epilepsy. 
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